Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.43    -0.01 (-0.41%)
Bid:
2.43
Ask:
2.44
Spread: 0.01 (0.412%)
Market Cap: $8.02b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

Half-year Report (Separate)

20 Jul 2017 07:00

RNS Number : 5446L
Commercial Intnl Bank (Egypt) SAE
20 July 2017
Β 
Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/5446L_-2017-7-19.pdf

Commercial International Bank (Egypt) S.A.E.

Separate Financial Statements

June 30th , 2017

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

FINANCIAL POSITION

As of June 30th , 2017

Amounts in EGP Thousands

Note

June 30, 2017

Β 

December 31, 2016

Β 

Assets

Cash and balances with central bank

15

19,497,893

10,522,040

Due from banks

16

58,552,276

58,011,034

Treasury bills and other governmental notes

17

43,092,546

39,177,184

Trading financial assets

18

1,531,630

2,445,134

Loans and advances to banks, net

19

367

159,651

Loans and advances to customers, net

20

91,221,870

85,991,914

Derivative financial instruments

21

57,218

269,269

Financial investments

- Available for sale

22

6,840,040

5,447,291

- Held to maturity

22

48,489,487

53,924,936

Investments in associates

23

9,750

10,500

Non current assets held for sale

42

222,665

428,011

Other assets

24

6,150,001

5,446,025

Intangible assets

41

434,027

499,131

Deferred tax assets (Liabilities)

32

178,253

181,308

Property, plant and equipment

25

1,355,916

1,338,629

Total assets

277,633,939

263,852,057

Liabilities and equity

Liabilities

Due to banks

26

1,585,589

3,008,996

Due to customers

27

245,162,646

231,965,312

Derivative financial instruments

21

156,580

331,091

Current tax liabilities

1,249,710

2,017,034

Other liabilities

29

3,654,428

3,579,330

Long term loans

28

146,287

160,243

Other provisions

30

1,558,854

1,514,057

Total liabilities

253,514,094

242,576,063

Equity

Issued and paid up capital

31

11,618,011

11,538,660

Reserves

34

8,543,172

3,443,319

Reserve for employee stock ownership plan (ESOP)

351,790

343,460

Total equity

20,512,973

15,325,439

Net profit for the period/year

3,606,872

5,950,555

Total equity and net profit for the period/ year

24,119,845

21,275,994

Total liabilities and equity

277,633,939

263,852,057

INCOME STATEMENT

As of June 30, 2017

Amounts in EGP Thousands

Note

June 30, 2017

Β 

June 30, 2016

Β 

Interest and similar income

13,197,728

8,595,146

Interest and similar expense

(7,454,779)

(4,061,260)

Net interest income

6

5,742,949

4,533,886

Fee and commission income

1,317,034

937,206

Fee and commission expense

(267,157)

(173,523)

Net fee and commission income

7

1,049,877

763,683

Dividend income

8

26,136

28,911

Net trading income

9

620,594

408,523

Profits on financial investments

22

323,564

59,058

Administrative expenses

10

(1,500,726)

(1,204,462)

Other operating (expenses) income

11

(528,307)

(316,881)

Goodwill impairment

41

-

(21,707)

Intangible assets amortization

41

(65,104)

(65,104)

Impairment charge for credit losses

12

(809,346)

(503,979)

Profit before income tax

4,859,637

3,681,928

Income tax expense

13

(1,249,710)

(957,424)

Deferred tax assets (Liabilities)

32 & 13

(3,055)

4,893

Net profit for the Period

3,606,872

2,729,397

Earnings per share

14

Basic

2.75

2.08

Diluted

2.71

2.05

CASH FLOW STATEMENT

As of June 30, 2017

Β 

Β 

Β 

Amounts in EGP Thousands

Β 

June 30, 2017

June 30, 2016

Cash flow from operating activities

Profit before income tax

4,859,637

3,681,928

Adjustments to reconcile net profit to net cash provided by operating activities

Fixed assets depreciation

170,012

134,956

Impairment charge for credit losses

809,346

503,979

Other provisions charges

148,424

51,547

Trading financial investments revaluation differences

(129,484)

124,229

Available for sale and held to maturity investments exchange revaluation differences

26,389

(263,567)

Goodwill impairment

-

21,707

Intangible assets amortization

65,104

65,104

Financial investments impairment charge

(121,734)

52,614

Utilization of other provisions

(21,939)

(1,800)

Other provisions no longer used

(97,879)

(37,312)

Exchange differences of other provisions

16,191

58,501

Profits from selling property, plant and equipment

-

(537)

Profits from selling financial investments

101,465

(16,243)

Profits (losses) from selling associates

-

(84,948)

Shares based payments

153,340

97,321

Impairment (Released) charges of non-current assets held for sale

(312,584)

-

Β 

Operating profits before changes in operating assets and liabilities

Β 

5,666,288

4,387,479

Net decrease (increase) in assets and liabilities

Due from banks

(6,167,220)

(608,433)

Treasury bills and other governmental notes

(4,707,972)

5,366,184

Trading financial assets

1,042,988

1,926,279

Derivative financial instruments

37,540

(92,958)

Loans and advances to banks and customers

(5,880,018)

(4,359,858)

Other assets

(563,155)

551,657

Non-Current Assets Held for Sale

205,346

-

Due to banks

(1,423,407)

(236,908)

Due to customers

13,197,334

14,318,023

Income tax obligations paid

(2,017,034)

(1,949,694)

Other liabilities

75,098

219,345

Net cash provided from operating activities

(534,212)

19,521,116

Cash flow from investing activities

Proceeds from selling subsidiary and associates

750

160,003

Payment for purchases of property, plant, equipment and branches constructions

(328,120)

(333,546)

Proceeds from redemption of held to maturity financial investments

10,030,359

2,671

Payment for purchases of held to maturity financial investments

(4,594,910)

(1,856,288)

Payment for purchases of available for sale financial investments

(1,916,162)

(2,703,756)

Proceeds from selling available for sale financial investments

683,505

2,670,755

Proceeds from selling non-current assets held for sale

500,867

-

Net cash used in investing activities

4,376,289

(2,060,161)

Cash flow from financing activities

Increase (decrease) in long term loans

(13,956)

13,524

Dividend paid

(1,350,207)

(1,463,450)

Capital Increase

79,351

68,057

Net cash used in financing activities

(1,284,812)

(1,381,869)

Β 

Net increase (decrease) in cash and cash equivalent during the period

2,557,265

16,079,086

Beginning balance of cash and cash equivalent

61,518,700

22,397,171

Cash and cash equivalent at the end of the period

64,075,965

38,476,257

Cash and cash equivalent comprise:

Cash and balances with central bank

19,497,893

11,251,951

Due from banks

58,552,276

36,100,865

Treasury bills and other governmental notes

43,092,546

16,949,949

Obligatory reserve balance with CBE

(10,832,277)

(8,412,172)

Due from banks with maturities more than three months

(3,339,073)

(464,462)

Treasury bills with maturity more than three months

(42,895,400)

(16,949,874)

Total cash and cash equivalent

64,075,965

38,476,257

Β 

COMMERCIAL INTERNATIONAL BANK (EGYPT) S.A.E

Β 

Β 

Separate statement of changes in shareholders' equity for the period ended June 30, 2016

Β 

Jun. 30, 2016

Issued and paid up capital

Legal reserve

General reserve

Special reserve

Reserve For A.F.S investments revaluation diff.

Banking risks reserve

Net profit for the period

Reserve for employee stock ownership plan

Total

Β 

EGP Thousands

Β 

Beginning balance

11,470,603

803,355

1,518,525

30,214

(2,202,463)

2,513

4,640,718

248,148

16,511,613

Β 

Capital increase

68,057

-

-

-

-

-

-

-

68,057

Β 

Transferred to reserves

-

232,008

3,035,878

564

-

-

(3,176,762)

(91,688)

-

Β 

Dividend paid

-

-

-

-

-

-

(1,463,450)

-

(1,463,450)

Β 

Net profit for the period

-

-

-

-

-

-

2,729,397

-

2,729,397

Β 

Net unrealised gain/(loss) on AFS

-

-

-

-

(793,189)

-

-

-

(793,189)

Β 

Transferred (from) to bank risk reserve

-

-

-

-

-

506

(506)

-

-

Β 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

97,321

97,321

Β 

Balance at the end of the period

11,538,660

1,035,363

4,554,403

30,778

(2,995,652)

3,019

2,729,397

253,781

17,149,749

Β 

Β 

Β 

Β 

Separate statement of changes in shareholders' equity for the peiord ended June 30, 2017

Β 

Jun. 30, 2017

Issued and paid up capital

Legal reserve

General reserve

Special reserve

Reserve For A.F.S investments revaluation diff.

Banking risks reserve

Net profit for the period

Reserve for employee stock ownership plan

Total

Β 

EGP Thousands

Β 

Beginning balance

11,538,660

1,035,363

4,554,403

30,778

(2,180,244)

3,019

5,950,555

343,460

21,275,994

Β 

Capital increase

79,351

-

-

-

-

-

-

-

79,351

Β 

Transferred to reserves

-

297,444

4,445,617

1,682

-

-

(4,599,733)

(145,010)

-

Β 

Dividend paid

-

-

-

-

-

-

(1,350,207)

-

(1,350,207)

Β 

Net profit for the period

-

-

-

-

-

-

3,606,872

-

3,606,872

Β 

Net unrealised gain/(loss) on AFS

-

-

-

-

354,495

-

-

-

354,495

Β 

Transferred (from) to bank risk reserve

-

-

-

-

-

615

(615)

-

-

Β 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

153,340

153,340

Β 

Balance at the end of the period

11,618,011

1,332,807

9,000,020

32,460

(1,825,749)

3,634

3,606,872

351,790

24,119,845

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IR BSGDRDXBBGRC
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.